Evaluation of Safety, Tolerability, Immunogenicity and Efficacy of a Novel Method in Specific Immunotherapy in Cat Allergic Patients: a Placebo Controlled Trial

NCT00718679 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Allergy to Cat Dander

Interventions

DRUG: IVN201
DRUG: Placebo

Sponsor

University of Zurich

Collaborators

[object Object]